Saad Eduardo B, Marrouche Nassir F, Saad Cynthia P, Ha Edward, Bash Dianna, White Richard D, Rhodes John, Prieto Lourdes, Martin David O, Saliba Walid I, Schweikert Robert A, Natale Andrea
The Cleveland Clinic Foundation, Desk F26, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.
Ann Intern Med. 2003 Apr 15;138(8):634-8. doi: 10.7326/0003-4819-138-8-200304150-00010.
Pulmonary vein isolation is a new, effective curative procedure for selected patients with atrial fibrillation. Pulmonary vein stenosis is a potential complication and may lead to symptoms that are often underrecognized.
To describe the clinical course and symptoms associated with pulmonary vein stenosis developing after ablation in the pulmonary veins.
Retrospective study.
Tertiary care referral center.
335 patients referred for catheter ablation of drug-refractory atrial fibrillation.
Pulmonary vein electrical isolation using radiofrequency catheter ablation.
Three months after ablation, patients underwent routine screening for pulmonary vein stenosis with spiral computed tomography. Screening was considered earlier if symptoms suggestive of stenosis developed and was repeated at 6 and 12 months if any pulmonary vein narrowing was observed. Pulmonary vein angiography and dilatation were offered to patients with severe (>70%) stenosis.
Severe pulmonary vein stenosis was detected in 18 patients (5% [95% CI, 3.2% to 8.4%]) a mean (+/-SD) of 5.2 +/- 2.6 months after ablation. Eight of these 18 patients (44%) were asymptomatic, but 8 (44%) reported shortness of breath, 7 (39%) reported cough, and 5 (28%) reported hemoptysis. Radiologic abnormalities were present in 9 patients (50%) and led to diagnoses of pneumonia (4 patients), lung cancer (1 patient), and pulmonary embolism (2 patients). Pulmonary vein stenosis was not considered in any patient during the initial work-up. Dilatation of the affected vein was performed in 12 patients. Postintervention lung perfusion scans revealed significant improvement in lung flow.
Severe pulmonary vein stenosis after catheter ablation of atrial fibrillation is associated with respiratory symptoms that frequently mimic more common diseases, often leading to erroneous diagnostic and therapeutic procedures. Awareness of this syndrome is important for proper and prompt management.
肺静脉隔离术是一种针对特定房颤患者的新型有效治疗方法。肺静脉狭窄是一种潜在并发症,可能导致一些常未被充分认识的症状。
描述肺静脉消融术后发生肺静脉狭窄的临床过程及相关症状。
回顾性研究。
三级医疗转诊中心。
335例因药物难治性房颤前来接受导管消融术的患者。
采用射频导管消融术进行肺静脉电隔离。
消融术后3个月,患者接受螺旋计算机断层扫描以进行肺静脉狭窄的常规筛查。如果出现提示狭窄的症状,则提前进行筛查;若观察到任何肺静脉狭窄,则在6个月和12个月时重复筛查。对严重(>70%)狭窄的患者进行肺静脉血管造影和扩张术。
18例患者(5%[95%CI,3.2%至8.4%])在消融术后平均(±标准差)5.2±2.6个月被检测出严重肺静脉狭窄。这18例患者中,8例(44%)无症状,但8例(44%)报告有气短,7例(39%)报告有咳嗽,5例(28%)报告有咯血。9例患者(50%)存在放射学异常,导致诊断为肺炎(4例)、肺癌(1例)和肺栓塞(2例)。在初始检查过程中,没有任何患者被考虑存在肺静脉狭窄。12例患者接受了患侧静脉扩张术。干预后肺灌注扫描显示肺血流有显著改善。
房颤导管消融术后的严重肺静脉狭窄与呼吸系统症状相关,这些症状常与更常见疾病相似,常导致错误的诊断和治疗程序。认识这种综合征对于正确及时的管理很重要。